Last updated on February 2018

Study to Assess the Safety Pharmacokinetics and Pharmacodynamics of Multiple Doses of COR-001


Brief description of study

This is a randomized, double-blind, placebo-controlled trial designed to evaluate the safety, pharmacokinetics, and pharmacodynamic effects of multiple doses of COR-001 or placebo

Clinical Study Identifier: NCT02868229

Contact Investigators or Research Sites near you

Start Over

Rahul Kakkar, M.D.

Nephrology Associates - Southeast Renal Research Institute
Chattanooga, TN United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.